Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Myeloma

Autologous and allogeneic transplantation for multiple myeloma at a single centre

Abstract

We report the results of a consecutive series of patients who underwent autologous (auto) (40), allogeneic (allo) (22) or syngeneic transplantation (2) for multiple myeloma (MM) at our centre. Median age at diagnosis was 45.5 (auto) and 43 (allo) years. Most patients had stage 2 (27% auto; 27% allo) or stage 3 (62% auto; 50% allo) disease and 73% demonstrated chemosensitivity prior to transplant. Median time from diagnosis to transplant was 18.6 months (auto) and 16.4 months (allo). Standard conditioning regimens were used. Median time to neutrophil engraftment was 11 days (7–18) (auto) and 18 days (13–24) (allo) and median time to platelet engraftment was 11 days (6–60) and 18 days (13–105), respectively. Ninety-day mortality was 5% (auto) and 27% (allo). Median follow-up was 15 months (6–48) (auto) and 42 months (24–52) (allo). Three-year progression-free survival (PFS) was 17 ± 10% (auto) and 22 ± 9% (allo) and 3-year overall survival (OS) was 74 ± 11% (auto) and 32 ± 10% (allo). Autologous transplantation for MM is a safe procedure with good OS although disease progression following transplant is frequent. Allogeneic transplantation has a high procedure-related mortality and PFS comparable to autologous transplantation but OS is poor. The early mortality and high OS of autologous transplantation in MM compares favourably with both the results of allogeneic transplantation and published results of standard therapy in this retrospective analysis.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Couban, S., Stewart, A., Loach, D. et al. Autologous and allogeneic transplantation for multiple myeloma at a single centre. Bone Marrow Transplant 19, 783–789 (1997). https://doi.org/10.1038/sj.bmt.1700738

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700738

Keywords

  • multiple myeloma
  • autologous bone marrow transplantation
  • allogeneic bone marrow transplantation

This article is cited by

Search

Quick links